A Phase I study of induction chemotherapy with S-1 and Cisplatin plus intraperitoneal administration of Docetaxel for gastric cancer with peritoneal dissemination - A Phase I study of intraperitoneal Docetaxcel with S-1 and Cisplatin for gastric cancer with peritoneal dissemination (KUGC05)

Department of Surgery Graduate School of Medicine, Kyoto University0 个研究点目标入组 15 人开始时间: 2010年1月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Active bleeding from the tumor 2)Paralysis of intestine or ileus 3)Diarrhea(watery stool) 4)Synchronous multicancer 5)Pleural effusion or ascites requiring control 6)Serious comorbidity including -Serious infection -Uncontrollable diabetes mellitus -Heart failure requireing control -Uncontrolled arrhythmia or angina -Severe phyciatric disease -Interstitial pneumonitis or fibroid lung 7)Myocardial infarction within 6 months 8)Patient who has experienced serious allergy for any drug or polysorbate 80 in the past 9)Patient who is pregnant or in lactation, or wish to become pregnant during this study.Male patient who intends to make someone pregnant during this study 10)Patient who requires continuous use of flucytosine 11)Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge

发起方

Department of Surgery Graduate School of Medicine, Kyoto University